Fantastic news as Stewart Bartlett joins Ferronova as chief executive. Stewart is Signostics co-founder and former chief operating officer and has successfully overseen the development of Signostic’s handheld ultrasound bladder scanner.
Stewart featured in the business section of the Advertiser.
Our collaboration with Professor Bernhard Wolfrum at the TUM has received a grant from the 2017 Australia-Germany Joint Research Cooperation scheme. This award will support joint research aimed at the development of point-of-care sensing devices for the detection of preeclampsia. Congratulation to Duy and Philip who coordinated the bid!
We look forward to host Bernhard and Philipp in June next year.
Congratulation to Ana for being awarded a 2018 Endeavour Research Fellowship!
Giri has been awarded a prestigious Fulbright Postgraduate Award – congratulation! This will strengthen our collaboration with Professor Eben Rosenthal at Stanford University.
Congratulation to Marnie for being awarded a New Adventure Fund grant. Her project builds on the current collaboration with the Women’s and Children’s Hospital and is aimed at demonstrating the feasibility of performing Whole Exome Sequencing on fetal cells isolated from maternal blood towards the development of improved NIPT procedures.
The image is the polymeric microfabricated filters she is developing to isolate circulating trophoblastic cells. Vote for her here.
Congratulation to Kyall for the publication of his article “Intestine-on-a-Chip Microfluidic Model for Efficient in Vitro Screening of Oral Chemotherapeutic Uptake” in ACS Biomaterials Science & Engineering.
Aidan has been awarded the 2016 Ian Wark medal. The Ian Wark Research Medal is awarded to the most outstanding Future Industries Institute (and before that the Ian Wark Research Institute) PhD graduate for the previous year. He joins a list of very successful awardees so congratulation.
We are pleased to announce that the Bionanoengineering group is now part of the ARC Centre of Excellence in Bio-Nano Science is a national innovator in bio-nano sciences and an incubator of the expertise and technological excellence required to develop next generation bio-responsive nanomaterials.
The objectives of the CBNS are to:
- be a centre of innovation in bio-nano science
- be an incubator of bio-nano science expertise
- develop the next generation of bio-responsive nanomaterials
- create methodologies and models to understand and predict how nanoengineered materials interact with biological systems
- exploit knowledge of the bio-nano interface to design materials
- develop modes of collaboration (between physical, biological and social sciences) to enable ‘upstream engagement’ in the early stages of research
The CBNS is funded by the Australian Research Council through the Centres of Excellence program. We are a collaboration between five Australian universities (Monash University and the Universities of Melbourne, Queensland, New South Wales and South Australia) where the majority of the Centre’s research is undertaken. The core research is enhanced through our partners where we link with other experts nationally and from around the world.